Picture of Korsana Biosciences logo

KRSA — Korsana Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Cyclerion Therapeutics Reports Full Year 2020 Financial Results And Corporate Update

Feb 25 (Reuters) - Cyclerion Therapeutics Inc  CYCN.O :
    * CYCLERION THERAPEUTICS REPORTS FULL YEAR 2020 FINANCIAL
RESULTS
AND CORPORATE UPDATE
    * CYCLERION THERAPEUTICS INC - PHASE 2A STUDY ALZHEIMER'S
DISEASE
WITH VASCULAR PATHOLOGY EXPECTED TO INITIATE IN MID-2021

Source text for Eikon:  ID:nGNX4gWVVw 
Further company coverage:  CYCN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Korsana Biosciences

See all news